Page 34 - AN-3-1

Advanced Neurology BTKi in brain diseases

57. Bame E, Tang H, Burns JC, et al. Next‐generation Bruton’s NOTCH1 protein in interleukin-6 and indoleamine
tyrosine kinase inhibitor BIIB091 selectively and potently 2,3-dioxygenase production by dendritic cells. J Biol Chem.
inhibits B cell and Fc receptor signaling and downstream 2014;289(11):7747-7762.
functions in B cells and myeloid cells. Clin Transl Immunol. doi: 10.1074/jbc.M113.519686
2021;10(6):e1295.
68. Moskowitz MA, Lo EH, Iadecola C. The science of
doi: 10.1002/cti2.1295 stroke: Mechanisms in search of treatments. Neuron.
58. Hopkins BT, Bame E, Bajrami B, et al. Discovery and 2010;67(2):181-198.
preclinical characterization of BIIB091, a reversible, selective doi: 10.1016/j.neuron.2010.07.002
BTK inhibitor for the treatment of multiple sclerosis. J Med
Chem. 2021;65(2):1206-1224. 69. Eltzschig HK, Eckle T. Ischemia and reperfusion-from
mechanism to translation. Nat Med. 2011;17(11):1391-1401.
doi: 10.1021/acs.jmedchem.1c00926
doi: 10.1038/nm.2507
59. Rijvers L, van Langelaar J, Bogers L, et al. Human T-bet+
B cell development is associated with BTK activity and 70. Iadecola C, Anrather J. The immunology of stroke: from
suppressed by evobrutinib. JCI Insight. 2022;7(16):e160909. mechanisms to translation. Nat Med. 2011;17(7):796-808.
doi: 10.1172/jci.insight.160909 doi: 10.1038/nm.2399
60. Bhargava P, Sol K, Reyes AA, et al. Imaging meningeal 71. Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of
inflammation in CNS autoimmunity identifies a therapeutic cerebral interleukin-17-producing gamma delta T cells
role for BTK inhibition. Brain. 2021;144(5):1396-1408. in the delayed phase of ischemic brain injury. Nat Med.
2009;15(8):946-950.
doi: 10.1093/brain/awab045
doi: 10.1038/nm.1999
61. Wang X, Jiao W, Lin M, et al. Resolution of inflammation
in neuromyelitis optica spectrum disorders. Mult Scler Relat 72. Zheng Z, Yenari MA. Post-ischemic inflammation:
Disord. 2019;27:34-41. Molecular mechanisms and therapeutic implications. Neurol
Res. 2004;26(8):884-892.
doi: 10.1016/j.msard.2018.09.040
doi: 10.1179/016164104X2357
62. Jarius S, Paul F, Fechner K, et al. Aquaporin-4 antibody testing:
Direct comparison of M1-AQP4-DNA-transfected cells with 73. Clarkson BDS, Ling C, Shi Y, et al. T cell-derived interleukin
leaky scanning versus M23-AQP4-DNA-transfected cells as (IL)-21 promotes brain injury following stroke in mice. J
antigenic substrate. J Neuroinflammation. 2014;11:129. Exp Med. 2014;211(4):595-604.
doi: 10.1186/1742-2094-11-129 doi: 10.1084/jem.20131377
63. Wu Y, Zhong L, Geng J. Neuromyelitis optica spectrum 74. Coll RC, Schroder K, Pelegrin P. NLRP3 and pyroptosis
disorder: Pathogenesis, treatment, and experimental blockers for treating inflammatory diseases. Trends
models. Mult Scler Relat Disord. 2019;27:412-418. Pharmacol Sci. 2022;43(8):653-668.
doi: 10.1016/j.msard.2018.12.002 doi: 10.1016/j.tips.2022.04.003
64. Qiao H, Mao Z, Wang W, et al. Changes in the BTK/NF-κB 75. Keller M, Rüegg A, Werner S, Beer HB. Active caspase-1
signaling pathway and related cytokines in different stages is a regulator of unconventional protein secretion. Cell.
of neuromyelitis optica spectrum disorders. Eur J Med Res. 2008;132(5):818-831.
2022;27(1):96. doi: 10.1016/j.cell.2007.12.040
doi: 10.1186/s40001-022-00723-x 76. Keestra-Gounder AM, Nagao PE. Inflammasome activation
65. O’Donnell JS, Massi D, Teng MWL, Mandala M. PI3K- by Gram-positive bacteria: Mechanisms of activation and
AKT-mTOR inhibition in cancer immunotherapy, redux. regulation. Front Immunol. 2023;14:1075834.
Semin Cancer Biol. 2017;48:91-103. doi: 10.3389/fimmu.2023.1075834
doi: 10.1016/j.semcancer.2017.04.015 77. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes
66. Khatlani TS, Ma Z, Okuda M, Onishi T. Molecular cloning in health and disease. Nature. 2012;481(7381):278-286.
and sequencing of canine T-cell costimulatory molecule doi: 10.1038/nature10759
(CD28). Vet Immunol Immunopathol. 2001;78(3-4):341-348.
78. Cavalli G, Colafrancesco S, Emmi G, et al. Interleukin 1α: A
doi: 10.1016/s0165-2427(01)00238-0 comprehensive review on the role of IL-1α in the pathogenesis
and treatment of autoimmune and inflammatory diseases.
67. Koorella C, Nair JR, Murray ME, Carlson LM,
Watkins SK, Lee KP. Novel regulation of CD80/CD86- Autoimmun Rev. 2021;20(3):102763.
induced phosphatidylinositol 3-kinase signaling by doi: 10.1016/j.autrev.2021.102763

Volume 3 Issue 1 (2024) 10 https://doi.org/10.36922/an.2184